Should Treatment of Mesothelioma Include Surgery? MARS2 Fails to Land.

Gulati, Shubham; Wolf, Andrea S; Flores, Raja M

Gulati, Shubham; Wolf, Andrea S; Flores, Raja M.

Afiliación

Gulati S; Department of Thoracic Surgery, Icahn School of Medicine at Mount Sinai, New York, New York.
Wolf AS; Department of Thoracic Surgery, Icahn School of Medicine at Mount Sinai, New York, New York.
Flores RM; Department of Thoracic Surgery, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: raja.flores@mountsinai.org.

Semin Thorac Cardiovasc Surg ; 2024 Jul 17.

Article en En | MEDLINE | ID: mdl-39029604

ABSTRACT

ABSTRACT

The presentation of the Mesothelioma and Radical Surgery 2 trial, a randomized controlled trial comparing pleurectomy/decortication to no surgery, injected new data into the contentious discussion surrounding the use of surgery in the management of diffuse pleural mesothelioma. We review the trial results in the context of the existing work surrounding the use of surgery in pleural mesothelioma.

Palabras clave

MARS2; extrapleural pneumonectomy; pleural mesothelioma; pleurectomy/decortication

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Semin Thorac Cardiovasc Surg Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA Año: 2024 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google